Mingfu Zhu
Geen lopende functies
Loopbaan van Mingfu Zhu
Eerdere bekende functies van Mingfu Zhu
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
20n Bio
 20n Bio BiotechnologyHealth Technology 20n Bio is a venture-backed startup based in Malvern, PA. The company's focus is on generating protein drugs in silico with desired biophysical, functional, and pharmacological properties. The company was founded in 2021 by Mingfu Zhu and is dedicated to using artificial intelligence to design novel protein therapeutics to address unmet medical needs. | Oprichter | - | - |
Panorama Medicine, Inc.
 Panorama Medicine, Inc. Miscellaneous Commercial ServicesCommercial Services Panorama Medicine, Inc. operates a drug discovery platform that integrates genomics, big data, and computing to find drugs that can treat diseases caused by errors during RNA processing. The company was founded by Yi Xing, Mingfu Zhu, and Douglas Black in 2018 and is headquartered in Philadelphia, PA. | Directeur/Bestuurslid | 01-01-2018 | - |
| Algemeen Directeur | 01-01-2018 | - | |
| Oprichter | 01-01-2018 | - |
Statistieken
Internationaal
| Verenigde Staten | 3 |
Operationeel
| Founder | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectoraal
| Commercial Services | 2 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Panorama Medicine, Inc.
Panorama Medicine, Inc. Miscellaneous Commercial ServicesCommercial Services Panorama Medicine, Inc. operates a drug discovery platform that integrates genomics, big data, and computing to find drugs that can treat diseases caused by errors during RNA processing. The company was founded by Yi Xing, Mingfu Zhu, and Douglas Black in 2018 and is headquartered in Philadelphia, PA. | Commercial Services |
20n Bio
20n Bio BiotechnologyHealth Technology 20n Bio is a venture-backed startup based in Malvern, PA. The company's focus is on generating protein drugs in silico with desired biophysical, functional, and pharmacological properties. The company was founded in 2021 by Mingfu Zhu and is dedicated to using artificial intelligence to design novel protein therapeutics to address unmet medical needs. | Health Technology |
- Beurs
- Insiders
- Mingfu Zhu
- Ervaring
